251 related articles for article (PubMed ID: 22129983)
1. Personalized medicine in oncology: next generation.
Chiang A; Million RP
Nat Rev Drug Discov; 2011 Dec; 10(12):895-6. PubMed ID: 22129983
[No Abstract] [Full Text] [Related]
2. Molecular Tumor Boards in Clinical Practice.
Luchini C; Lawlor RT; Milella M; Scarpa A
Trends Cancer; 2020 Sep; 6(9):738-744. PubMed ID: 32517959
[TBL] [Abstract][Full Text] [Related]
3. Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.
Beer PA; Cooke SL; Chang DK; Biankin AV
Ann Oncol; 2019 Nov; 30(11):1691-1694. PubMed ID: 31665210
[No Abstract] [Full Text] [Related]
4. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
MacConaill LE; Lindeman NI; Rollins BJ
JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
[No Abstract] [Full Text] [Related]
5. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
6. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
[No Abstract] [Full Text] [Related]
7. [Personalized medicine in oncology].
Lörsch AM; Jung J; Lange S; Pfarr N; Mogler C; Illert AL
Pathologie (Heidelb); 2024 May; 45(3):180-189. PubMed ID: 38568256
[TBL] [Abstract][Full Text] [Related]
8. [Precision Oncology: Approaching the Target].
Hiddemann W
Dtsch Med Wochenschr; 2017 Nov; 142(22):1637. PubMed ID: 29078208
[No Abstract] [Full Text] [Related]
9. [The breakthrough of personalized medicine, new hopes and new challenges].
Flippot R; Massard C; Auclin E; Azria D; Bourien H; Rochigneux P; Schernberg A; Verlingue L; Zafrani L; Vignot S
Bull Cancer; 2017 Sep; 104(9):735-743. PubMed ID: 28807365
[TBL] [Abstract][Full Text] [Related]
10. Genomic Medicine Takes the Stage, Again!
Tempero M
J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
[No Abstract] [Full Text] [Related]
11. Precision medicine strategies in oncology: mixed approaches to matched therapies.
Borcoman E; Le Tourneau C
Future Oncol; 2018 Jan; 14(2):105-109. PubMed ID: 29224361
[No Abstract] [Full Text] [Related]
12. Toward next-generation cancer immunotherapy: 10th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012.
Kloke BP; Kutscher S; Rae R; Kvistborg P; Britten CM; Hadrup SR
Cancer Immunol Immunother; 2013 May; 62(5):975-81. PubMed ID: 23299564
[No Abstract] [Full Text] [Related]
13. The future of oncology therapeutics.
Mansinho A; Boni V; de Miguel M; Calvo E
Expert Rev Anticancer Ther; 2017 Jul; 17(7):563-565. PubMed ID: 28504011
[No Abstract] [Full Text] [Related]
14. Future Clinical Trials: Genetically Driven Trials.
Astsaturov I
Surg Oncol Clin N Am; 2017 Oct; 26(4):791-797. PubMed ID: 28923231
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials in the era of personalized oncology.
Maitland ML; Schilsky RL
CA Cancer J Clin; 2011; 61(6):365-81. PubMed ID: 22034206
[TBL] [Abstract][Full Text] [Related]
16. Integrated patient and tumor genetic testing for individualized cancer therapy.
Hertz DL; McLeod HL
Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
[TBL] [Abstract][Full Text] [Related]
17. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
18. [Cancer: three eras of personalized medicine].
Jordan B
Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
[TBL] [Abstract][Full Text] [Related]
19. Precision oncology: where next?
Gore M; Larkin J
Lancet Oncol; 2015 Dec; 16(16):1593-5. PubMed ID: 26678189
[No Abstract] [Full Text] [Related]
20. Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps.
Printz C
Cancer; 2020 Jan; 126(2):239-240. PubMed ID: 31917472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
